A carregar...
More Unnecessary Imaginary Worlds – Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease
A number of commentaries have been published over the past 4 years by the present author on the manifest flaws in the reference case value assessment framework of the Institute for Economic and Clinical Review. The recent release of the evidence report on sickle cell disease continues ICER’s commitm...
Na minha lista:
| Publicado no: | Innov Pharm |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
University of Minnesota Libraries Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051927/ https://ncbi.nlm.nih.gov/pubmed/34007618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v11i2.3123 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|